TLDR:
- Boeing shares fell 3.2% as renewed safety scrutiny revived concerns about investor confidence.
- The stock lost roughly $5.6 billion in market value during Thursday’s trading session.
- Stronger deliveries, cash flow and analyst optimism continue supporting Boeing’s broader recovery story.
- Investors now await evidence that production improvements can withstand renewed regulatory and reputational pressure.
Boeing Co. (BA) stock came under renewed pressure Thursday as fresh attention on the company’s long-running safety challenges overshadowed signs of an improving financial recovery.
Shares dropped 3.2% to close at $215.10, down $7.09 for the session. Based on roughly 790.37 million shares outstanding, the decline erased approximately $5.6 billion from Boeing’s market capitalization.
The decline came as safety concerns surrounding the aerospace manufacturer returned to the spotlight following the release of Netflix’s Freefall: A Reckoning for Boeing. The documentary, which debuted August 19, revisits allegations from whistleblowers regarding Boeing’s safety culture and production practices. The claims presented in the film remain allegations, but their renewed visibility adds another layer of scrutiny for a company attempting to rebuild confidence with regulators, customers and investors.
Safety Scrutiny Returns
The latest market reaction does not appear to be driven solely by the documentary. Boeing also fell alongside major aerospace companies during Thursday’s broader market weakness. RTX Corp. declined 3.66%, while Lockheed Martin fell 3%. The S&P 500 also finished lower, losing 0.87%.
Still, Boeing’s larger decline compared with the benchmark highlights how company-specific concerns can amplify broader market pressure.
The renewed attention comes as the Federal Aviation Administration continues monitoring Boeing’s production and aircraft quality. Under a new inspection directive, 471 U.S.-registered 737 MAX aircraft are subject to inspections beginning September 10.
The FAA estimates that the initial visual inspection could cost approximately $40,035 for each aircraft, while more detailed inspections involving eddy-current testing could reach $160,140 per cycle.
Those direct inspection expenses are relatively small compared with Boeing’s market-value decline. The more important issue for shareholders is whether additional findings could result in repairs, production interruptions, higher costs or delays to the company’s recovery.
Boeing Shows Signs Of Recovery
Despite the renewed scrutiny, Boeing has made measurable progress in several areas of its business.
The company reported second-quarter revenue of $24.56 billion, representing an 8% increase from the same period a year earlier. Commercial aircraft deliveries also increased to 171 from 150, marking a 14% improvement.
Cash generation provided another positive signal. Boeing reported free cash flow of $631 million in the second quarter, compared with negative free cash flow of $200 million during the same period in 2025.
The company’s commercial operating margin also improved to negative 2.7% from negative 5.1%, although it remains below zero.
Boeing’s backlog has meanwhile climbed to a record $715 billion, including more than 6,200 commercial aircraft. That backlog gives the company substantial future demand, but converting those orders into reliable deliveries remains crucial to the recovery story.
Chief Executive Kelly Ortberg has emphasized rebuilding confidence as a central priority for the company. Boeing’s challenge is now demonstrating that improvements in production and cash generation can continue while regulators maintain close oversight.
FAA Oversight Remains Critical
Regulatory developments provide some encouragement for Boeing investors.
The FAA said in July that eight months of monitoring had shown steady improvements in production quality. The agency also restored Boeing’s ability to issue airworthiness certificates for its 737 MAX and 787 aircraft, although inspectors remain involved at Boeing facilities.
The FAA subsequently granted certification for the 737 MAX-7 on August 3. The aircraft includes changes such as updated flight-control software, revised cockpit alert systems and an enhanced engine anti-ice system.
These developments suggest Boeing is making progress in addressing regulatory requirements. However, the continued presence of FAA inspectors means the company remains under a level of oversight that investors will continue to monitor.
Any new quality issue, production setback or regulatory action could potentially undermine confidence in Boeing’s turnaround.
Wall Street Still Sees Upside
Despite Thursday’s selloff, Wall Street’s broader view of Boeing remains relatively constructive.
Of 28 analysts surveyed in August, 23 rated the stock either Buy or Strong Buy, while five assigned a Hold rating. There were no Sell or Strong Sell recommendations in the cited analyst snapshot.
The average price target stands at $274.69, implying potential upside of approximately 27.7% from Boeing’s Thursday close of $215.10. The targets range from $246 to $305.
However, the bullish outlook depends heavily on Boeing maintaining its operational recovery. Higher deliveries, improving cash flow and continued regulatory progress could strengthen the case for a higher valuation. Conversely, new safety findings or production disruptions could reinforce the discount investors have placed on the stock.
For now, Thursday’s selloff illustrates that Boeing’s recovery is not simply a financial story. The company must also convince investors that its improvements in manufacturing quality, regulatory compliance and corporate culture can be sustained.
The relatively modest direct cost of the latest inspections may therefore be less important than what the renewed scrutiny represents. For Boeing, rebuilding trust remains a critical part of restoring the company’s long-term investment case.


